Long COVID — also called post-COVID-19 condition (PCC) or post-acute sequelae of SARS-CoV-2 infection (PASC) — is a cluster of symptoms that persist or develop after an initial SARS-CoV-2 infection and cannot be explained by another diagnosis. The World Health Organization defines it clinically as symptoms that begin within three months of infection, last at least two months, and affect daily functioning [1].

Background

Long COVID has been recognized since early in the pandemic, when patients, clinicians, and researchers noticed that a substantial fraction of people did not return to baseline weeks or months after their acute illness. Estimates of prevalence vary widely depending on case definition, time since infection, and population studied, and research teams continue to refine how the condition is defined and counted [3].

Long COVID is not a single disease. Current research points to multiple overlapping subgroups with different combinations of symptoms and likely different biological mechanisms [2][3].

Symptoms: what research describes

Across large studies, the most commonly reported long COVID symptoms include [2][4][8][9]:

Fatigue — often profound and worsened by exertion
Post-exertional malaise — worsening of symptoms after even mild physical or mental activity
Cognitive impairment (often called "brain fog") — attention, memory, and processing-speed difficulties
Shortness of breath and reduced exercise tolerance
Chest pain and palpitations
Postural tachycardia and orthostatic intolerance
Headache
Sleep disturbance
Loss or alteration of smell and taste
Gastrointestinal symptoms
Joint and muscle pain
Depression and anxiety

A large JAMA paper by Thaweethai et al. from the RECOVER Initiative developed a symptom-based definition of PASC using data from thousands of participants [3].

What the research has established

Long COVID can follow both severe and mild initial infections; it is not exclusively a consequence of hospitalization [4][5].
Large electronic health record studies have documented increased risk of neurological and psychiatric outcomes in the months after COVID-19 [6].
Risk of long COVID appears to be lower (but not zero) after breakthrough infection in vaccinated individuals [7].
Multiple organ systems can be involved — cardiovascular, pulmonary, neurological, and others [2][5].
Current research describes multiple plausible biological contributors: persistent virus or viral fragments, immune dysregulation, microclots, autonomic nervous system dysfunction, and reactivation of latent viruses such as Epstein-Barr [2][10]. None of these alone explain every case.

What remains unclear

The precise prevalence in different populations and after different variants
Whether there are reliable biomarkers for diagnosis
Which treatments work for which subgroups — few randomized trials have yet reported definitive results
The long-term trajectory: many patients improve over months, but how many fully recover is still being studied
The relationship between long COVID and ME/CFS

Current management approaches

NICE published rapid guidance in the UK for managing the long-term effects of COVID-19 [8]. Core principles, broadly consistent with CDC and international recommendations, include:

Comprehensive initial assessment to rule out alternative diagnoses (e.g., cardiac disease, thyroid dysfunction, iron deficiency)
Symptom-directed treatment — for example, addressing sleep disturbance, orthostatic intolerance, pain, and mood symptoms
Pacing — carefully managing activity levels to avoid post-exertional crashes; for people with post-exertional malaise, traditional graded exercise approaches can worsen symptoms and must be adapted
Multidisciplinary rehabilitation for patients with complex or multi-system symptoms
Referral to specialist long COVID clinics where available

Research into specific interventions (antivirals, immune modulators, symptomatic therapies) is ongoing. Some trials have reported preliminary results; others are still recruiting. Patients should discuss with their doctor whether participation in a registered clinical trial is appropriate.

Prevention

The most consistently supported prevention strategy is avoiding or attenuating SARS-CoV-2 infection in the first place — through vaccination, up-to-date boosters where recommended, and sensible precautions during high-transmission periods. A Nature Medicine study examining breakthrough infections reported that vaccinated individuals had a reduced but nonzero risk of long COVID after infection [7].

Frequently asked questions

How long does long COVID last? It varies widely. Many people improve over months; some have persistent symptoms for a year or more. Long-term trajectory data are still emerging [2][8].

Is long COVID a mental-health condition? No — the evidence is consistent that it involves real biological processes, though mental health symptoms (anxiety, depression) commonly co-occur and deserve treatment in their own right [2][6].

Will vaccines help me if I already have long COVID? Some patients report symptom improvement after vaccination, others report no change or temporary worsening. Evidence is mixed and individual [2].

Should I just "push through" exercise? Not if you have post-exertional malaise — pushing through often worsens symptoms. A careful pacing approach, guided by a clinician who understands PEM, is usually recommended [8].

When to talk to a doctor

Persistent symptoms more than 4–8 weeks after a COVID-19 infection
New chest pain, significant shortness of breath, or fainting — these can have urgent causes
Symptoms that limit your daily activities or work
New cognitive symptoms
Depression, anxiety, or thoughts of self-harm

A doctor on Heliodoc can help you rule out other causes of your symptoms, develop a management plan, and refer you to specialist services or post-COVID clinics where they exist. If you experience severe symptoms — such as chest pain or severe breathlessness — contact your local emergency services.

Long COVID: What Research Has Established (and What Remains Unclear)